NCT00557349View on ClinicalTrials.gov

Ulcer Prevention Study in Post Gastric Bypass Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

March 31, 2008

Conditions
Marginal Ulcers
Interventions
DRUG

Omeprazole

40mg dose administered as a suspension or capsule as physician directs daily at bedtime for 14 weeks beginning day of hospital discharge following gastric bypass surgery.

DRUG

Famotidine

40mg dose administered as a suspension or capsule as physician directs daily at bedtime for 14 weeks beginning day of hospital discharge following gastric bypass surgery.

Trial Locations (1)

65212

University of Missouri Health Care, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT00557349 - Ulcer Prevention Study in Post Gastric Bypass Patients | Biotech Hunter | Biotech Hunter